Case File
efta-02580536DOJ Data Set 11OtherEFTA02580536
Date
Unknown
Source
DOJ Data Set 11
Reference
efta-02580536
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Jeffrey Epstein <[email protected]>
Sent:
Friday, February 7, 2014 5:09 PM
To:
Tazia Smith
Subject:
Re: ...barrier note (us and euro combo) and BMY stabilizing.... [C]
speadsheet out returnds for me thanks
On Fri, Feb 7, 20=4 at 10:29 AM, Tazia Smith <
Classification: Co=fidential
Good Morning Jeffrey -
<mailto
> wrote:
I called be I'd priced this short dated S&P Feb22 1780/1770 put spread trade to fade the post-NFP bounce but
the S&P just retraced a quick 6 points and ate into the payout. Be back -- and/or let me know if you hat that that view!
What were your thoughts on the Eurostoxx + Russell 2000 Contingent Min/Barrier note? I thought the
combining the euro and US views, uncapped upside was attractive. Monday may be better day to trade, but please let
me know if you liked the structure so I can re-price.
13mo Contingent Minimum Return Worst-of Note (Eurostoxx50 and Russell 2000):
WoF SXSE/RTY
11.5% Cant Min Return
80% Barrier Daily obs.
uncapped
max loss: 100%
Indicative levels only, subject to market movement, source: DB AWM Structured Solutions, 2/5/14.
Within your healthcare theme, BMY starting to stabilize, consider initiating your position BMY (2.0 in your
percentages).
6mo charts below for your convenience.
BMY 6mo Price History
Speak with you soon,
Tazia
EFTA_R1_01756152
EFTA02580536
Tazia Smith
Director I Key Client Partners - US
Deutsche Bank Securities Inc
Deutsche Asset & Wealth Management
345 Park Avenue, 26th Floor
New York, NY 10154
Tel.
>
Fa
Mobile
Email
<mailto
This communication may contain confidential and/=r privileged information.
If you are not the intended recipient (or have received this communicationar> in error) please notify the sender
immediately and destroy this
communication. Any unauthorized copying, disclosure or distribution of thear> material in this communication
is strictly forbidden.
Deutsche Bank does not render legal or tax advice, and the information
contained in this communication should not be regarded as such.
The information contained in this commun=cation is
confidential, may be attorney-client privileged, may
constitute inside i=formation, and is intended only for
the use of the addressee. It is the=property of
Jeffrey Epstein
Unauthorized use, disclosure or copying=of this
communication or any part thereof is strictly prohibited
and may be unla=ful. If you have received this
communication in error, please notify us=immediately by
return e-mail or by e-mail to [email protected] <mailto:[email protected]> , and
destroy this communication and all copies thereof,
including all attachm=nts. copyright -all rights reserved
2
EFTA_R1_01756153
EFTA02580537
Technical Artifacts (4)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.